This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Live coverage has ended. The full story is below.
Astera Labs (NASDAQ: ALAB | ALAB Price Prediction) reports fourth-quarter 2025 earnings today after the bell. The AI connectivity specialist has beaten estimates in all eight consecutive quarters since going public, and investors want to know if that streak continues amid massive hyperscaler infrastructure buildouts.
Momentum Meets High Expectations
The stock has surged 16.5% over the past week to $184.65, driven by the company’s announcement of a new R&D center in Tel Aviv and Haifa with plans to hire hundreds of employees. That move signals confidence, but it also raises the bar for today’s report. Shares are up 79% over the past year, far outpacing Broadcom’s 47% gain in the same period.
Consensus expects EPS of $0.51 and revenue around $249.55 million. That would represent roughly 38% year-over-year EPS growth from Q4 2024’s $0.37. Last quarter, the company posted revenue of $230.6 million, beating estimates by $0.10 per share. Sequential momentum has been strong, with revenue climbing from $159.4 million in Q1 to $191.9 million in Q2 to $230.6 million in Q3.
What Matters Most This Quarter
I’ll be watching gross margins closely. The company maintained 76.2% gross margins in Q3, but any sign of pricing pressure or product mix shifts could move shares. Operating leverage is improving fast. The company swung from an operating loss of $8.9 million in Q3 2024 to operating income of $55.4 million in Q3 2025.
Key areas to watch include guidance and customer concentration. Meta announced $135 billion in CapEx, Google committed $185 billion, and Microsoft is spending aggressively on AI infrastructure. Astera’s connectivity solutions are critical plumbing for these buildouts, but investors need to hear how much visibility management has into 2026 demand. The expanded Scorpio X-Series roadmap targeting a $20 billion scale-up switching market by 2030 provides a long runway, but execution in the near term is what matters.
Analysts will likely press management on competitive positioning against Broadcom and Marvell, design win timing with hyperscalers, and whether the Israel R&D expansion impacts near-term profitability. The company trades at 154x trailing earnings, so much of the growth story is already priced in. Any stumble on guidance or margin trajectory could trigger profit-taking.
Contact [email protected] for any questions or corrections.